曲妥珠单抗
曲妥珠单抗
乳腺癌
医学
肿瘤科
内科学
残余物
癌症
计算机科学
算法
作者
Charles E. Geyer,M. Untch,Chiun‐Sheng Huang,Max S. Mano,Eleftherios P. Mamounas,Norman Wolmark,Priya Rastogi,Andreas Schneeweiß,Andrés Redondo,Hans Holger Fischer,Véronique D’Hondt,Alison Conlin,Valentina Guarneri,Irene Wapnir,Christian Jackisch,Claudia Arce-Salinas,Peter A. Fasching,Michael P. DiGiovanna,John Crown,Pia Wuelfing
标识
DOI:10.1056/nejmoa2406070
摘要
As compared with trastuzumab, T-DM1 improved overall survival with sustained improvement in invasive disease-free survival among patients with HER2-positive early breast cancer with residual invasive disease after neoadjuvant therapy. (Funded by F. Hoffmann-La Roche/Genentech; KATHERINE ClinicalTrials.gov number, NCT01772472.).
科研通智能强力驱动
Strongly Powered by AbleSci AI